ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 980 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $118,155 | +238.6% | 1,515 | +194.2% | 0.03% | +210.0% |
Q1 2024 | $34,891 | +0.6% | 515 | 0.0% | 0.01% | -16.7% |
Q4 2023 | $34,685 | -0.5% | 515 | 0.0% | 0.01% | -20.0% |
Q3 2023 | $34,876 | -5.4% | 515 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $36,859 | +3.1% | 515 | 0.0% | 0.02% | -6.2% |
Q1 2023 | $35,746 | +102031.4% | 515 | 0.0% | 0.02% | 0.0% |
Q4 2022 | $35 | -99.9% | 515 | 0.0% | 0.02% | +14.3% |
Q3 2022 | $28,000 | -36.4% | 515 | -22.0% | 0.01% | -30.0% |
Q2 2022 | $44,000 | 0.0% | 660 | 0.0% | 0.02% | +17.6% |
Q1 2022 | $44,000 | +15.8% | 660 | 0.0% | 0.02% | +6.2% |
Q4 2021 | $38,000 | -5.0% | 660 | 0.0% | 0.02% | -5.9% |
Q3 2021 | $40,000 | 0.0% | 660 | 0.0% | 0.02% | -5.6% |
Q2 2021 | $40,000 | +60.0% | 660 | +33.3% | 0.02% | +50.0% |
Q1 2021 | $25,000 | 0.0% | 495 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $25,000 | -7.4% | 495 | 0.0% | 0.01% | -13.3% |
Q3 2020 | $27,000 | +3.8% | 495 | 0.0% | 0.02% | -11.8% |
Q2 2020 | $26,000 | +18.2% | 495 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $22,000 | -12.0% | 495 | 0.0% | 0.02% | +6.2% |
Q4 2019 | $25,000 | +13.6% | 495 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $22,000 | – | 495 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |